Axa S.A. Travere Therapeutics, Inc. Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$7.64 - $17.25 $308,656 - $696,900
-40,400 Reduced 75.37%
13,200 $118,000
Q2 2023

Aug 14, 2023
SELL
$15.3 - $22.61 $4.58 Million - $6.76 Million
-299,187 Reduced 84.81%
53,600 $823,000
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $1.45 Million - $1.87 Million
81,575 Added 30.08%
352,787 $7.93 Million
Q4 2022

Feb 14, 2023
SELL
$18.47 - $26.14 $97,613 - $138,149
-5,285 Reduced 1.91%
271,212 $5.7 Million
Q3 2022

Feb 14, 2023
BUY
$22.91 - $28.63 $1.06 Million - $1.33 Million
46,407 Added 20.17%
276,497 $6.81 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $1.06 Million - $1.33 Million
46,407 Added 20.17%
276,497 $6.81 Million
Q2 2022

Feb 14, 2023
BUY
$20.94 - $30.01 $1.01 Million - $1.45 Million
48,457 Added 26.68%
230,090 $5.58 Million
Q2 2022

Aug 15, 2022
BUY
$20.94 - $30.01 $1.01 Million - $1.45 Million
48,457 Added 26.68%
230,090 $5.58 Million
Q1 2022

Feb 14, 2023
SELL
$23.61 - $30.6 $2.24 Million - $2.9 Million
-94,864 Reduced 34.31%
181,633 $4.68 Million
Q1 2022

May 13, 2022
BUY
$23.61 - $30.6 $3.78 Million - $4.9 Million
160,233 Added 748.75%
181,633 $4.68 Million
Q4 2021

Feb 14, 2022
BUY
$24.34 - $31.17 $520,876 - $667,038
21,400 New
21,400 $664,000
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $1.87 Million - $3.6 Million
-143,900 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$14.11 - $26.4 $2.54 Million - $4.75 Million
-179,818 Reduced 55.55%
143,900 $2.1 Million
Q1 2021

May 14, 2021
BUY
$23.37 - $31.77 $3.12 Million - $4.24 Million
133,518 Added 70.2%
323,718 $8.08 Million
Q4 2020

Feb 12, 2021
BUY
$19.17 - $27.87 $3.65 Million - $5.3 Million
190,200 New
190,200 $5.18 Million

Others Institutions Holding TVTX

# of Institutions
192
Shares Held
84.5M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email